secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-04-13T23:59:59+00:00
Accession:  0001575872-23-000556
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP extends business combination deadline to May 19, 2023 with Estrella deposit of $45,511
--------------------------------------------------------------------------------

- Estrella Biopharma deposited $45,511 ($0.05 per public share) into trust to extend deadline from April 19 to May 19, 2023.
- Extension Note is unsecured, non-interest bearing, payable upon business combination close or termination.
- Estrella has right to convert note into private shares at $10.00 per share before closing.
- Company may extend monthly through July 19, 2023 per charter by depositing $45,511 each month.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000556/0001575872-23-000556-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587223000556/uptd-20230303.htm
  HTML page:      https://secwatch.observer/filing/0001575872-23-000556

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer